BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21918803)

  • 1. Sixty percent 10-year survival of patients with chondrosarcoma after local recurrence.
    Lin PP; Alfawareh MD; Takeuchi A; Moon BS; Lewis VO
    Clin Orthop Relat Res; 2012 Mar; 470(3):670-6. PubMed ID: 21918803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the Width of a Surgical Margin Associated with the Outcome of Disease in Patients with Peripheral Chondrosarcoma of the Pelvis? A Multicenter Study.
    Tsuda Y; Evans S; Stevenson JD; Parry M; Fujiwara T; Laitinen M; Outani H; Jeys L
    Clin Orthop Relat Res; 2019 Nov; 477(11):2432-2440. PubMed ID: 31453886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locally recurrent chondrosarcoma of the pelvis and limbs can only be controlled by wide local excision.
    Laitinen MK; Parry MC; Le Nail LR; Wigley CH; Stevenson JD; Jeys LM
    Bone Joint J; 2019 Mar; 101-B(3):266-271. PubMed ID: 30813783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and prognostic factors in conventional G1 chondrosarcoma.
    Fromm J; Klein A; Baur-Melnyk A; Knösel T; Lindner L; Birkenmaier C; Roeder F; Jansson V; Dürr HR
    World J Surg Oncol; 2019 Sep; 17(1):155. PubMed ID: 31481076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation therapy is associated with fewer recurrences in mesenchymal chondrosarcoma.
    Kawaguchi S; Weiss I; Lin PP; Huh WW; Lewis VO
    Clin Orthop Relat Res; 2014 Mar; 472(3):856-64. PubMed ID: 23709273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pelvic chondrosarcomas: surgical treatment options.
    Deloin X; Dumaine V; Biau D; Karoubi M; Babinet A; Tomeno B; Anract P
    Orthop Traumatol Surg Res; 2009 Oct; 95(6):393-401. PubMed ID: 19801212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What Factors Are Associated with Treatment Outcomes of Japanese Patients with Clear Cell Chondrosarcoma?
    Nakayama R; Hayakawa K; Kobayashi E; Endo M; Asano N; Yonemoto T; Kawashima H; Hamada K; Watanabe I; Futani H; Goto T; Nishida Y; Ozaki T
    Clin Orthop Relat Res; 2020 Nov; 478(11):2537-2547. PubMed ID: 32297725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones.
    Dierselhuis EF; Goulding KA; Stevens M; Jutte PC
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD010778. PubMed ID: 30845364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivorship analysis in patients with periosteal chondrosarcoma.
    Papagelopoulos PJ; Galanis EC; Mavrogenis AF; Savvidou OD; Bond JR; Unni KK; Sim FH
    Clin Orthop Relat Res; 2006 Jul; 448():199-207. PubMed ID: 16826117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and survival in conventional chondrosarcoma: A single institution review.
    Chen YC; Wu PK; Chen CM; Tsai SW; Chen CF; Chen WM
    J Chin Med Assoc; 2020 Jul; 83(7):669-673. PubMed ID: 32221156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing an Evidence-based Followup Schedule for Bone Sarcomas Based on Local Recurrence and Metastatic Progression.
    Cipriano C; Griffin AM; Ferguson PC; Wunder JS
    Clin Orthop Relat Res; 2017 Mar; 475(3):830-838. PubMed ID: 27339121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic Potential of Grade I Chondrosarcoma of Bone: Results of a Multi-institutional Study.
    Andreou D; Gilg MM; Gosheger G; Werner M; Hardes J; Pink D; Leithner A; Tunn PU; Streitbürger A
    Ann Surg Oncol; 2016 Jan; 23(1):120-5. PubMed ID: 26350369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary chondrosarcoma arising from osteochondroma: outcomes and prognostic factors.
    Tsuda Y; Gregory JJ; Fujiwara T; Abudu S
    Bone Joint J; 2019 Oct; 101-B(10):1313-1320. PubMed ID: 31564158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does local recurrence impact survival in low-grade chondrosarcoma of the long bones?
    Schwab JH; Wenger D; Unni K; Sim FH
    Clin Orthop Relat Res; 2007 Sep; 462():175-80. PubMed ID: 17514007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chondrosarcoma of bone: lessons from 46 operated cases in a single institution.
    de Camargo OP; Baptista AM; Atanásio MJ; Waisberg DR
    Clin Orthop Relat Res; 2010 Nov; 468(11):2969-75. PubMed ID: 20473598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does intensity of surveillance affect survival after surgery for sarcomas? Results of a randomized noninferiority trial.
    Puri A; Gulia A; Hawaldar R; Ranganathan P; Badwe RA
    Clin Orthop Relat Res; 2014 May; 472(5):1568-75. PubMed ID: 24249538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for survival and local control in chondrosarcoma of bone.
    Fiorenza F; Abudu A; Grimer RJ; Carter SR; Tillman RM; Ayoub K; Mangham DC; Davies AM
    J Bone Joint Surg Br; 2002 Jan; 84(1):93-9. PubMed ID: 11837841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What Happens to the Articular Surface After Curettage for Epiphyseal Chondroblastoma? A Report on Functional Results, Arthritis, and Arthroplasty.
    Farfalli GL; Slullitel PA; Muscolo DL; Ayerza MA; Aponte-Tinao LA
    Clin Orthop Relat Res; 2017 Mar; 475(3):760-766. PubMed ID: 26831477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database.
    Schneiderman BA; Kliethermes SA; Nystrom LM
    Clin Orthop Relat Res; 2017 Mar; 475(3):799-805. PubMed ID: 26975384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncologic outcome after local recurrence of chondrosarcoma: Analysis of prognostic factors.
    Kim HS; Bindiganavile SS; Han I
    J Surg Oncol; 2015 Jun; 111(8):957-61. PubMed ID: 26040553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.